Quanterix Announces $50,000 in Grants to Support Promising Oncology Research
Grants to be awarded to researchers with the most transformative
ideas for disrupting precision medicine through biomarker research in
Quanterix’
“Our Simoa technology powers groundbreaking research that can disrupt
the way diseases are diagnosed and treated, and we want to make sure
that technology remains within reach for the most promising
discoveries,” said
This year, special consideration will be given to proposals leveraging the Simoa CorPlex 10 Plex planar array or other Simoa planar arrays, which enable the accuracy, sensitivity and reproducibility needed to address many of today’s unmet needs in oncology, immuno-oncology and other research areas. Specifically, proposals focused on tumor-shrinking markers, hot and cold tumor differentiation, cytokine release syndrome, cytokine release neurotoxicity, CAR T-cell therapies, patient stratification, predictive biomarkers, and liquid biopsies will be given special attention as they address some of the greatest unmet needs in research today.
“Biomarker research continues to provide a treasure trove of information powering medical breakthroughs and we are optimistic that together we’ll be able to drive change,” continued Hrusovsky. “We feel there is a lot of untapped potential in this area that could help us take down the most lethal diseases, including cancer. That’s why we’re seeking applicants with a focus across these specific areas in which biomarkers have already shown significant promise.”
Quanterix’ state-of-the-art
To be considered for the grant, all interested parties must submit their
proposals by
To submit your proposal and learn more about the Accelerator Grant Program, click here.
About
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Words such as "may," "will," "expect,"
"plan," "anticipate," "estimate," "intend" and similar expressions (as
well as other words or expressions referencing future events, conditions
or circumstances) are intended to identify forward-looking statements.
Forward-looking statements in this news release are based on Quanterix’
expectations and assumptions as of the date of this press release. Each
of these forward-looking statements involves risks and uncertainties.
Factors that may cause Quanterix’ actual results to differ from those
expressed or implied in the forward-looking statements in this press
release are discussed in Quanterix’ filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20190516005710/en/
Source:
PAN Communications
Lindsay Poole, 617-502-4300
quanterix@pancomm.com